On January 18, Liu Chao, Secretary of the Party Committee and Executive Director of Chongqing Tongjunge Pharmaceutical Factory of Taiji Group, and his party came to Wanhe Pharmaceutical Group, where the two sides conducted in-depth exchanges on the development direction and cooperation goals in 2022, and signed a strategic agreement for 2022.
Meeting site
Tang Xianwei, chairman of Wanhe Pharmaceutical Group, Zhou Ya, executive deputy general manager, Zhang Congcai, director of the comprehensive business department, Liu Cheng, general manager of the agency sales division of Tongjunge Pharmaceutical Factory, and Liu Yi, deputy general manager of the marketing center, attended the meeting.
Liu Chao, Party Secretary and Executive Director of Chongqing Tongjunge Pharmaceutical Factory of Taiji Group
Liu Chao said that in recent years, Tongjunge Pharmaceutical Factory has integrated traditional Chinese medicine production technology and modern production methods through the construction of digital intelligent workshops, and successfully achieved the intelligent manufacturing goal of automated, intelligent and digital quality control of the production of proprietary Chinese medicines. He stressed that Tongjunge Pharmaceutical Factory will take this cooperation as an opportunity to fully open its products to Wanhe Pharmaceutical Group, try to cooperate with diversified varieties and groups, and help Wanhe brand continue to rise.
Tang Xianwei, chairman of Wanhe Pharmaceutical Group
Tang Xianwei said that Tongjunge Pharmaceutical Factory, as a long-established chinese medicine enterprise with a history of more than 110 years, has always been one of the most important strategic partners of Wanhe Pharmaceutical Group. In recent years, Wanhe Pharmaceutical Group has adhered to the product strategy of brand drugs, assured drugs and curative drugs, and strengthened in-depth cooperation with brand pharmaceutical companies and foreign pharmaceutical companies. He hopes to further deepen cooperation with Tongjunge Pharmaceutical Factory, conduct in-depth discussions on resource complementarity and innovative cooperation models, and seize the new opportunity of the current development of the pharmaceutical retail chain industry to achieve win-win results.
Signing ceremony
At the meeting, the two sides signed the strategic goals for 2022, which will further deepen the strategic cooperation between the two sides, promote the integration of resources, promote win-win development, and work together to create a new model of mutual benefit and win-win cooperation in the industry. Taiji Group Chongqing Tongjunge Pharmaceutical Factory Co., Ltd. is a state-owned listed company with a history of 100 years integrating the cultivation of medicinal materials and the development, production and sales of proprietary Chinese medicines, and is the only chinese proprietary medicine manufacturer in Chongqing that also has the honors of "Chinese Time-honored Brand" and "National Intangible Cultural Heritage". (Textu/Mo Shuo)
【Source: Upstream News】